1. Home
  2. RZLT vs VYGR Comparison

RZLT vs VYGR Comparison

Compare RZLT & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RZLT
  • VYGR
  • Stock Information
  • Founded
  • RZLT 2010
  • VYGR 2013
  • Country
  • RZLT United States
  • VYGR United States
  • Employees
  • RZLT N/A
  • VYGR N/A
  • Industry
  • RZLT Biotechnology: Pharmaceutical Preparations
  • VYGR Biotechnology: Pharmaceutical Preparations
  • Sector
  • RZLT Health Care
  • VYGR Health Care
  • Exchange
  • RZLT Nasdaq
  • VYGR Nasdaq
  • Market Cap
  • RZLT 292.0M
  • VYGR 309.7M
  • IPO Year
  • RZLT N/A
  • VYGR 2015
  • Fundamental
  • Price
  • RZLT $4.59
  • VYGR $6.27
  • Analyst Decision
  • RZLT Strong Buy
  • VYGR Strong Buy
  • Analyst Count
  • RZLT 8
  • VYGR 9
  • Target Price
  • RZLT $11.63
  • VYGR $16.44
  • AVG Volume (30 Days)
  • RZLT 391.3K
  • VYGR 501.0K
  • Earning Date
  • RZLT 02-11-2025
  • VYGR 11-12-2024
  • Dividend Yield
  • RZLT N/A
  • VYGR N/A
  • EPS Growth
  • RZLT N/A
  • VYGR N/A
  • EPS
  • RZLT N/A
  • VYGR 0.47
  • Revenue
  • RZLT N/A
  • VYGR $163,784,000.00
  • Revenue This Year
  • RZLT N/A
  • VYGR N/A
  • Revenue Next Year
  • RZLT N/A
  • VYGR N/A
  • P/E Ratio
  • RZLT N/A
  • VYGR $13.45
  • Revenue Growth
  • RZLT N/A
  • VYGR 3.40
  • 52 Week Low
  • RZLT $0.81
  • VYGR $5.19
  • 52 Week High
  • RZLT $6.19
  • VYGR $11.72
  • Technical
  • Relative Strength Index (RSI)
  • RZLT 35.67
  • VYGR 49.10
  • Support Level
  • RZLT $4.90
  • VYGR $6.08
  • Resistance Level
  • RZLT $5.29
  • VYGR $6.44
  • Average True Range (ATR)
  • RZLT 0.34
  • VYGR 0.34
  • MACD
  • RZLT -0.05
  • VYGR 0.04
  • Stochastic Oscillator
  • RZLT 15.32
  • VYGR 38.42

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: